Found: 4
Select item for more details and to access through your institution.
Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population.
- Published in:
- American Health & Drug Benefits, 2019, v. 12, n. 3, p. 151
- By:
- Publication type:
- Article
The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers... [including commentary by Quang T. Nguyen].
- Published in:
- American Health & Drug Benefits, 2017, v. 10, n. 4, p. 202
- By:
- Publication type:
- Article
Longitudinal Commercial Claims-Based Cost Analysis of Diabetic Retinopathy Screening Patterns... [including commentary by Sharon Glave Frazee].
- Published in:
- American Health & Drug Benefits, 2015, v. 8, n. 6, p. 300
- By:
- Publication type:
- Article
The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 855, doi. 10.2147/CEOR.S184048
- By:
- Publication type:
- Article